Want to see CNTN full AI Analyst Report?
Canton Strategic Holdings (CNTN) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Nalmefene | Pruritus, Primary Biliary Cholangitis | Phase II | Not Yet Recruiting | TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis | Dec 03, 2024 | ― |
| Nalmefene | Healthy | Phase I | Completed | An Evaluation of The Absolute Bioavailability of TH104 | Dec 27, 2023 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Nalmefene | Phase II | Pruritus, Primary Biliary Cholangitis | Not Yet Recruiting | TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis | Dec 03, 2024 | ― |
| Nalmefene | Phase I | Healthy | Completed | An Evaluation of The Absolute Bioavailability of TH104 | Dec 27, 2023 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Canton Strategic Holdings, Inc. (CNTN) have in its pipeline
Canton Strategic Holdings CNTN is currently developing the following drugs: Nalmefene. These drug candidates are in various stages of clinical development as the company works toward FDA approval.